Last Updated On 7/27/2023 6:09:05 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Exelixis |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Taiho Pharmaceutical |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Genentech |
| Recipient: You |
| Company: Jazz Pharmaceuticals |
| Recipient: You |
| Company: Merus |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: QED Therapeutics |
| Recipient: You |
| Company: Rafael Pharmaceuticals |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Immunovaccine |
| Recipient: You |
| Company: Seagen |
| Recipient: You |
| Company: Novocure |
| Recipient: You |
| Company: Nucana |
| Recipient: You |
| Company: Loxo/Lilly |
| Recipient: You |
| Company: Faeth Therapeutics |
| Recipient: You |
| Company: NGM Biopharmaceuticals |
| Recipient: You |
| Company: Actuate Therapeutics |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|